A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide

Tara Gurung,1 Deepson S Shyangdan,1 Joseph Paul O’Hare,2 Norman Waugh1 1Warwick Evidence, 2Division of Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, UK Background: Dulaglutide is a new, long-acting glucagon-like peptide analogue in the treatment of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gurung T, Shyangdan DS, O’Hare JP, Waugh N
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/bc350032f4514bc8a491ff16d157897f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!